Catalyst Wire Dossier Catalyst Wire Dossier

guanfacine HCl

guanfacine · Shire
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for guanfacine HCl, covering 2014-05-23 to 2014-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl [Phase 3]

See pricing